Literature DB >> 3358734

Quantification of cellular proliferation in experimental proliferative vitreoretinopathy.

D L Hatchell1, T McAdoo, S Sheta, R T King, J V Bartolomé.   

Abstract

Proliferation of host cells from around the optic nerve head has recently been implicated in the development of experimental proliferative vitreoretinopathy in rabbit eyes injected with homologous fibroblasts. We used liquid scintillation spectrometry to quantitate the tritiated thymidine incorporation into cells in the vitreous, retina, and optic nerve head following intravitreal injection of 250,000 homologous dermal fibroblasts. Cellular proliferation peaked three days after injection of the fibroblasts. The amount of tritiated thymidine incorporation that occurred three days following injection of irradiated homologous fibroblasts (incapable of cellular division) was not significantly different than that following injection of normal homologous fibroblasts, indicating that host cells were responsible for most of the cellular proliferation. Treatment with fluorouracil or triamcinolone acetonide completely arrested cellular proliferation following injection of normal fibroblasts.

Entities:  

Mesh:

Year:  1988        PMID: 3358734     DOI: 10.1001/archopht.1988.01060130731033

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.

Authors:  D B Chandler; T Hida; G Rozakis; V S Forbes; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  Hypoxia precedes the development of experimental preretinal neovascularization.

Authors:  J T Handa; B A Berkowitz; C A Wilson; N Ando; H A Sen; G J Jaffe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

4.  Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.

Authors:  C M Yang; K R Olsen; E Hernandez; S W Cousins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.

Authors:  Y N Hui; H C Liang; Y S Cai; B Kirchhof; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

7.  Experimental traction retinal detachment in the cat.

Authors:  C A Wilson; J A Khawly; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases.

Authors:  G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.